INBRIJA

Drug Acorda Therapeutics, Inc
Total Payments
$6.4M
Transactions
32,747
Doctors
6,308
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $243,264 2,200 1,219
2023 $524,424 4,933 1,980
2022 $387,448 4,627 1,826
2021 $822,546 4,618 1,645
2020 $1.3M 4,238 1,512
2019 $3.1M 12,131 3,583

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5.0M 16,235 79.0%
Consulting Fee $609,841 208 9.6%
Travel and Lodging $364,339 1,631 5.7%
Food and Beverage $360,427 14,558 5.7%
Education $686.29 115 0.0%

Top Doctors Receiving Payments for INBRIJA — Page 7

Doctor Specialty Location Total Records
, MD Student in an Organized Health Care Education/Training Program Miami, FL $3,986 2
, M.D Neurology Brooklyn, NY $3,955 1
, M.D Psychiatry Arroyo Grande, CA $3,754 6
, D.O Neurology Atlanta, GA $3,725 1
, MD, PHD Clinical Genetics (M.D.) New York, NY $3,725 1
, MD Neurology Phoenix, AZ $3,725 1
, MD Neurology Providence, RI $3,725 1
, MD Neurology Chicago, IL $3,725 1
, MD Neurology Cincinnati, OH $3,725 1
, PA-C Physician Assistant Georgetown, TX $3,473 20
, M.D Student in an Organized Health Care Education/Training Program Sumter, SC $3,421 30
, M.D Neurology Islip, NY $3,313 27
, M.D Neurology Kansas City, MO $3,287 3
, MD Specialist Port Charlotte, FL $3,017 37
, D.O., PH.D Neurology Rochester, NY $2,991 7
, MD Neurology Dallas, TX $2,960 2
, M.D Neurology Dallas, TX $2,913 5
, MD, PHD Specialist Columbus, OH $2,838 2
, MBBS Neurology Omaha, NE $2,825 1
, MD Neurology Philadelphia, PA $2,825 1
, MD Neurology Rochester, NY $2,825 1
, M.D Neurology Indianapolis, IN $2,825 1
, APRN Nurse Practitioner Hastings, NE $2,775 6
, M.D Neurology Blaine, MN $2,612 2
, ARNP Nurse Practitioner Tacoma, WA $2,467 24

About INBRIJA

INBRIJA is a drug associated with $6.4M in payments to 6,308 healthcare providers, recorded across 32,747 transactions in the CMS Open Payments database. The primary manufacturer is Acorda Therapeutics, Inc.

Payment data is available from 2019 to 2024. In 2024, $243,264 was paid across 2,200 transactions to 1,219 doctors.

The most common payment nature for INBRIJA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5.0M, 79.0% of total).